Subscribe to Newsletter

Clinical Trials

Manufacture Business Practice

Binding thermodynamics of substituted diaminopyrimidine renin inhibitors

| Sponsored by Malvern Panalytical

See how thermodynamics can be used to improve your lead optimization process.

Business & Regulation Business Practice

The Realities of a Digital World

Advanced digital technologies are sweeping through the world and changing the way we live our lives and do business.

Manufacture Business Practice

Utilization of kinITC in AFFINImeter

| Sponsored by Malvern Panalytical

This application note describes how and when can kinetic information be retrieved from ITC power curves.

Discovery & Development Clinical Trials

Cancer Complexity

| James Ritchie

Clinical development is outmoded; we are witnessing serious attrition in cancer R&D. Perhaps it’s time to live and die by the mantra: “no biomarker, no trial”.

Discovery & Development Clinical Trials

The Cautious Comeback of Oral Peptides

| David J. Brayden

Despite clinical failures in the 1990s, pharma is (cautiously) ready to try again with oral peptide formulations.

Discovery & Development Clinical Trials

Clinical Trial Clarity

| Charlotte Barker

Drug makers and regulators are taking steps towards transparency, but is it enough?

Manufacture Business Practice

Nanoparticle Tracking Analysis: Principles and Methodology

It is well established that the use of nanotechnology in medicine and more specifically drug delivery is spreading rapidly.

Manufacture Business Practice

Laser diffraction and automated imaging: complementary techniques for nasal spray development

The techniques of laser diffraction and automated particle imaging support the fast, cost-effective development of nasal spray products, simultaneously providing the data required for regulatory compliance. This paper examines their application.

Manufacture Biosimilars

Taylor Dispersion Analysis for assessing the self-association and stability of Insulin

| Sponsored by Malvern Panalytical

Taylor Dispersion measurements are used to monitor self-association and oligomeric state in a variety of buffer conditions.

Discovery & Development Clinical Trials

What Patients Want

| Abbe Steel

Most pharma companies want to become more patient focused. But how? You could start by simply listening more carefully.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register